Haber Görseli
EU Startup
May 11, 2026 | 11:31

Bologna’s Cellply secures €7.15 million to develop tools for faster immunotherapy and cell therapy development

Cellply, a Bologna-based DeepTech startup developing analytical tools enabling a deep characterisation of cancer immunotherapies, cell therapies and...
Full Story at Source

Related News

Haber
Church & Dwight to Present at the dbAccess Global Consumer Conference
Haber
Law Offices of Frank R. Cruz Encourages Phreesia Inc. (PHR) Shareholders To Inquire About Securities Fraud Class Action
Haber
ICE Canola Midday: Rising on Spillover From Crude
Haber
New Report Finds AI Agents Are Devouring the Internet's Scarce Addresses